> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# ACRO Says More Wearable Technology Coming
- URL: https://www.fdaweb.com/acro-says-more-wearable-technology-coming/
- Published: 2016-05-10T12:00:00.000Z
- Updated: 2026-09-14T21:01:30.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5135616

The Association of Clinical Research Organizations (ACRO) [says](http://www.acrohealth.org/survey-points-to-wearable-technology-social-media-recruitment/?ref=fdaweb.com) that a [survey](http://www.acrohealth.org/wp-content/uploads/2014/03/ACRO-Response-FDA-Technologies%5FFinal.pdf?ref=fdaweb.com) indicates a coming rapid increase in use of wearable technology and an upsurge in social media for patient recruitment. “ACRO members are at the forefront of developing and implementing new clinical trial technologies to enhance efficiency and improve the patient experience,” says ACRO senior vice president for policy and public affairs **John Lewis**. “But the biopharmaceutical industry is heavily regulated so there are several areas where we are requesting that FDA consult with stakeholders and provide additional guidance to encourage the adoption of these exciting technologies. We thank FDA for requesting input on this issue.”

Other areas in which ACRO members identified substantial benefit/increase in adoption include risk-based monitoring, electronic informed consent, and the use of near real-time trial data analytics. Lewis said that FDA has already provided guidance on risk-based monitoring and electronic consent and the industry has been actively implementing those tools and technologies.